Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 31 to 40 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
BioIsoprene
by
DuPont
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Biological Fungicide - Willaertia magna
by
Amoéba
Biotech components:
Bacteria
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (4 years ago)
Date last modified:
2020/12/18 14:35 (4 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Food & Agriculture
Market status:
Under Development
+
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Other
Production process:
Open Release
Source:
Web search
Trading symbol:
ALMIB
(EPA)
Value chain stage:
Finished Product
Biological Self-Assembly: pre-programmed biological organisms
by
BIOHM
Biotech components:
N/A
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/11/19 09:36 (6 years ago)
Date last modified:
2018/11/19 09:36 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Industrial
Market status:
Early Stage Concept
+
More information needed
Organization type(s):
Private Company
Product categories:
Construction
+
Design
+
Resource Extraction
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Biologically Functional Assemblies of Robust Microenvironments (BioFARMS)
by
Caltech
Biotech components:
Microbe
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
3,498,401 USD
Funding types:
Government
Industry:
Science
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Biolon DDDA
by
Verdezyne
Biotech components:
Plant
Business models:
B2B
Country of production:
Malaysia
Country of distribution:
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:44 (6 years ago)
Known funding amount:
86,500,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Biopolymer I6001
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:56 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer I6003rp
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:56 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer Mvera B5010 (Mirel)
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer Mvera B5011 (Mirel)
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
